3,4-二氯苯-1,2-二醇 | 3978-67-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 3,4-二氯苯-1,2-二醇
• 中文别名: 1,4-二氯儿茶酚
• 英文名称: 3,4-dichlorocatechol
• 英文别名: 3,4-dichloro-1,2-benzenediol；3,4-dichlorobenzene-1,2-diol
• CAS: 3978-67-4
• 化学式: C₆H₄Cl₂O₂
• 分子量: 179.003
• InChiKey: HFSXRRTUWAPWSJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

制备方法与用途

生物活性方面，3,4-氯代邻苯二酚是假单胞菌绿光RW71氯邻苯二酚1,2-二加氧酶的一种广谱底物。

反应信息

• 作为反应物：
  描述：

  3,4-二氯苯-1,2-二醇 在 sodium hydroxide 、 三氯化铝 、 硫酸 、 铬酸 、 sodium hydride 、 对甲苯磺酸 作用下， 以 1,4-二氧六环 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 31.0h， 生成 7,8-dichloro-6-(2-ethylacryloyl)-2,3-dihydro-1,4-benzodioxin-2-carboxylic acid
  参考文献：
  名称：

  2,3-二氢-1,4-苯并二恶英衍生物的合成。二。5（或6）-酰基2,3-二氢-1,4-苯并二恶英衍生物：新的苯氧乙酸利尿剂。

  摘要：

  5(和6)-酰基-7, 8-二氯-2, 3-二氢-1, 4-苯并二噁烯-2-羧酸（VI）及相关化合物被合成并测试了其利尿和抗高血压特性。这些化合物（VI）是通过3, 4-二氯-1, 2-二羟基苯（2）与溴代环氧乙烷（EBH）在碱的存在下反应，并进行Friedel-Crafts酰化，或者通过对2进行酰化后与EBH反应，随后氧化而制备的。对7, 8-二氯二氢苯并二噁烯-2-基甲醇（15a）进行酰化得到相应的5-和6-酰基化合物（17和10）。当分子中存在5-酰基取代基时，通常观察到利尿活性。化合物20e表现出强的利尿和抗高血压活性，类似于吲达克仑（II）。

  DOI：

  10.1248/cpb.36.3404
• 作为产物：
  描述：

  邻二氯苯 在 Pseudomonas putida F₁ 作用下， 以 phosphate buffer 为溶剂， 反应 2.0h， 生成 3,4-二氯苯-1,2-二醇
  参考文献：
  名称：

  Biocatalytic Synthesis of Polycatechols from Toxic Aromatic Compounds

  摘要：

  A process is described in which toxic aromatic compounds are converted by toluene dioxygenase and in turn toluene cis-dihydrodiol dehydrogenase to catechols which are further polymerized by peroxidase-catalyzed oxidation producing polycatechols. Three approaches for obtaining catechols were employed: (1) addition of halogenated aromatics to P. putida F1, resulting in the accumulation of halogenated catechols; (2) inhibition of catechol 2,3-dioxygenase of P. putida F1 by known aromatic and aliphatic inhibitors; and (3) overexpression of toluene dioxygenase and toluene cis-dihydrodiol dehydrogenase genes in E coli JM109. The process is suitable for producing novel catechols that upon oxidation may yield polymers with unique properties, presenting a tool for producing tailor-made biopolymers. Formation of 3-chlorocatechol from chlorobenzene, 3,4-dichlorocatechol from 1,2-dichlorobenzene, and catechol from benzene and their subsequent oxidation and polymerization was demonstrated. Oxidation of catechol yielded polymers with molecular weights of up to 4000 Daltons. Their apparently high water solubility eliminates the need for water-miscible solvents. In aqueous solution oxidation of catechols was rapid, yet the presence of 20%, 30%, and 40% ethanol, resulted in a rate decrease of 31%, 95%, and 93%, respectively. The advantage is that significantly less peroxidase is required for performing the reactions if miscible solvents are not employed. Furthermore, water-soluble polymers may be desirable for many applications.

  DOI：

  10.1021/es035458q

文献信息

• Benzodioxole derivatives, pharmaceutical compositions and use
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：US04965282A1

  公开（公告）日：1990-10-23

  Novel benzodioxole derivative of the formula: ##STR1## wherein R.sup.1 is a lower alkyl group, a lower alkoxy-lower alkyl group, phenyl group or pyridyl group, R.sup.2 is hydrogen atom or a halogen atom and R.sup.3 is hydrogen atom or a lower alkyl group, and a salt thereof are disclosed. Said derivative (I) and a salt thereof have potent diuretic, saluretic and uricosuric activities.

  式(I)所示的新型苯并二噁烷衍生物：##STR1##其中R1为低级烷基、低级烷氧基低级烷基、苯基或吡啶基，R2为氢原子或卤素原子，R3为氢原子或低级烷基，及其盐被公开。所述衍生物(I)及其盐具有强效的利尿、盐皮质激素样和尿酸排泄作用。
• [EN] SULFAMATE AND SULFAMIDE DERIVATIVES FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS<br/>[FR] DÉRIVÉS DE SULFAMATE ET DE SULFAMIDE POUR LE TRAITEMENT DE L'ÉPILEPSIE ET DE TROUBLES APPARENTÉS
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2006007435A1

  公开（公告）日：2006-01-19

  The present invention is directed to novel sulfamide and sulfamate derivatives, pharmaceutical composlons containing them and their use in the treatment of epilepsy and related disorders.

  本发明涉及新型磺胺酰胺和磺酸酯衍生物，包含它们的药物组合物以及它们在治疗癫痫和相关疾病中的用途。
• USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR LOWERING LIPIDS AND LOWERING BLOOD GLUCOSE LEVELS
  申请人：Smith-Swintosky L. Virginia

  公开号：US20070155821A1

  公开（公告）日：2007-07-05

  The present invention is a method for the glucose related disorders and lipid related disorders comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) or formula (II) as herein defined. The present invention is further directed to methods of treatment comprising co-therapy with an anti-diabetic agent, and anti-lipid agent and/or an anti-obesity agent.

  本发明涉及一种治疗葡萄糖相关疾病和脂质相关疾病的方法，包括向需要的受试者施用一种或多种新型苯并杂环磺胺衍生物的治疗有效量，其化学结构如公式(I)或公式(II)所定义。本发明还涉及治疗方法，包括与抗糖尿病药物、抗脂质药物和/或抗肥胖药物联合治疗。
• USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF DEPRESSION
  申请人：Smith-Swintosky L. Virginia

  公开号：US20070155827A1

  公开（公告）日：2007-07-05

  The present invention is a method for the treatment of depression comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as herein defined. The present invention is directed to a method for the treatment of depression, which includes mono-therapy and alternatively, co-therapy with at least one antidepressant.

  本发明涉及一种治疗抑郁症的方法，包括向需要的受试者施用一种或多种新型苯并杂环磺酰胺衍生物的治疗有效量，其化学式为(I)和(II)。本发明涉及一种治疗抑郁症的方法，包括单独治疗和/或与至少一种抗抑郁药物联合治疗。
• USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN
  申请人：Smith-Swintosky L. Virginia

  公开号：US20070155822A1

  公开（公告）日：2007-07-05

  The present invention is a method for the treatment of pain comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as described herein. The present invention is further directed to methods for the treatment of pain comprising co-therapy with analgesic agent(s) and a compound of formula (I) or formula (II) as described herein.

  本发明涉及一种用于治疗疼痛的方法，包括向需要的受试者施用一种或多种根据本文描述的新型苯并杂环磺酰胺衍生物的治疗有效量。本发明还涉及一种治疗疼痛的方法，包括与镇痛剂联合治疗，并根据本文描述的化合物的公式(I)或公式(II)。